Feature

Perspectives

The Key Factors Driving Low Participation in the Enhancing Oncology Model

02/12/2024

Theresa Dreyer, MPH, investigates the challenges leading to a substantial decline in participation among academic oncology practices within the Enhancing Oncology Model.

Theresa Dreyer, MPH,...

02/12/2024

Journal of Clinical Pathways

Research Reports

Enhancing Multidisciplinary Team Processes in Lung Cancer Care: A Self-Assessment Toolkit and Best Practices

02/09/2024

Adrien Moucquot ;

Poka Cui ;

Heather Moses ;

David Dellamonica ;

Peter Blanshard ;

María Teresa Campos-Partera ;

Poka Cui and colleagues completed a literature review along with interviews involving lung cancer multidisciplinary teams from 24 medical centers across Europe and Canada. In this report, they also introduce a comprehensive self-assessment...

Poka Cui and colleagues...

02/09/2024

Journal of Clinical Pathways

Research Reports

The Impact of Social Determinants of Health Beyond Race on Survival in Metastatic Prostate Cancer: A Systematic Literature Review

12/14/2023

Bhakti Arondekar , PhD, MBA;

Imtiaz A. Samjoo , MSc, PhD;

Alexandra Hall , MPH;

Alexander Niyazov , PharmD, MPH;

Manvir Rai , BSc;

Stephen J. Freedland , MD;

Austin Lansing , MSc;

Emily Rosta , MSc;

Jonathan L. Nazari , PharmD;

A systematic literature review by Stephen J. Freedland, MD, and colleagues summarizes the current evidence relating to social determinants of health beyond race and survival in patients with metastatic prostate cancer.

A systematic literature review...

12/14/2023

Journal of Clinical Pathways

Research Reports

Clinical and Economic Impact of Implementing HealthPathways at a Musculoskeletal Radiology Department

12/13/2023

Ramakrishna Kishore , MBBS;

Khurram Hashmi , MBBCh;

Maria Dyban , LLM;

Kausik Mukherjee , MBBS;

Kathleen Lyons , MBBCh;

Anna Kuczynska , MBBCh;

Simon R. Davies , MBBCh, MD;

Simon R. Davies, MBBCh, and colleagues investigate the impact of HealthPathways on management and primary care clinicians in a musculoskeletal radiology department.

Simon R. Davies, MBBCh, and...

12/13/2023

Journal of Clinical Pathways

Quality Outlook

Saving Lives from Preventable Cancer: Solutions for Geographic Disparities in HPV Vaccination

10/03/2023

Tom Valuck , MD, JD;

Anne DiSalvo , MPH, MBA;

Kendall Logan , MPH;

Erik Muther ;

This is the first of a 3-part blog series that explores issues related to HPV vaccination rates in the US. In this blog, vaccination disparities are explored among the highest and lowest performing states.

This is the first of a 3-part...

10/03/2023

Journal of Clinical Pathways

Review

NGS Testing in Non–Small Cell Lung Cancer

09/19/2023

Winston Wong , PharmD;

Gordon Kuntz ;

Winston Wong, PharmD, and Gordon Kuntz provide an update on the current status of the research and barriers for using next-generation sequencing in NSCLC and summarize the discussion and next steps that the NGS Institute’s NSCLC Subcommittee...

Winston Wong, PharmD, and Gordon...

09/19/2023

Journal of Clinical Pathways

OCPC: IN SESSION

Artificial Intelligence in Oncology: The Wins, The Challenges, and How We Can Deliver on Personalized Cancer Care

09/19/2023

Matthew Biancalana , PhD;

Tushar Pandey , MBA;

Mathew Biancalana, PhD, and Tushar Pandey, MBA, discuss how artificial intelligence can enhance the field of precision medicine and help unburden physicians from laborious and repetitive tasks in diagnostic analyses.

Mathew Biancalana, PhD, and...

09/19/2023

Journal of Clinical Pathways

Research Reports

Off-Label Use of Precision Oncology Therapeutics in Advanced Solid Cancers Following Identification of Associated Variants via Multicancer Next-Generation Sequencing Panel: A Real-World Evidence Pilot Study

09/19/2023

Nicole Zhang , MPH;

Rebecca Nagy , MS;

Kathryn Lang , MD;

Julie Wiedower , PhDc;

Jayati Saha , PhD, MPH;

Julie Wiedower, PhDc, and colleagues analyze the frequency of real-world off-label therapy utilization post–comprehensive genomic profiling via liquid biopsy in precision oncology.

Julie Wiedower, PhDc, and...

09/19/2023

Journal of Clinical Pathways

Research Reports

Oncology Pathways Drive Adoption of High-Quality Treatment Regimens and Deliver Drug Cost Savings

08/07/2023

Robinson Ortiz , MD;

Rama Al Ghannam , PharmD;

Stephen Hamilton , MD;

Timothy Dollear , MD, MS;

Kathryn Christensen , MD, MS;

Eric Gratias , MD, FAAP;

Kathryn Christensen, MS, and colleagues share the initial results of the launch of Cigna and eviCore Healthcare’s Oncology Value-based Pathways program.

Kathryn Christensen, MS, and...

08/07/2023

Journal of Clinical Pathways

Perspectives

Leveraging Quality Measurement to Drive Equitable Cancer Care for Transgender Individuals

08/07/2023

Theresa Schmidt , MA, PMP, CSPO;

Tom Valuck , MD, JD;

Don S. Dizon , MD;

Nina Regenold , MSc;

Will Nolan ;

Elizabeth Donckels , MSPH;

Elizabeth Donckels, MSPH, and colleagues investigate several measurement tactics to promote cancer care quality improvement for transgender individuals.

Elizabeth Donckels, MSPH, and...

08/07/2023

Journal of Clinical Pathways

Current Issue

October 2024

Volume 10

Issue 5

Current Issue

Issue Archive

Special Reports

Sponsored

JCP Special Report

The Value of Tissue-Based Genomic Profiling in Oncology

09/17/2024

Innovations in precision oncology have helped healthcare providers to create more personalized treatment plans and improve patient outcomes. View this special report to learn more.

Innovations in precision...

09/17/2024

Journal of Clinical Pathways

Sponsored

Special Report

Shedding Light on Non-Small Cell Lung Cancer & Its Impact on Patients

04/03/2023

This supplement aims to raise awareness about non-small cell lung cancer (NSCLC) and its impact on patients by providing comprehensive information to help improve early detection and appropriate care.

This supplement aims to raise...

04/03/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Brukinsa® (Zanubrutinib) for Chronic Lymphocytic Leukemia

03/31/2023

In this product monograph, read an interview with Jeff P. Sharman, MD, as he discusses important BRUKINSA® trial data including efficacy, safety, dosing, administration, and other relevant data. These key findings supported the Food and Drug...

In this product monograph, read...

03/31/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Tumor Lysis Syndrome: Early Diagnosis and Management

01/04/2023

This review summarizes the diagnosis, pathophysiology, and evidence-based guidelines for the prevention and management of tumor lysis syndrome, a common, acute, life-threatening disease primarily in patients with hematologic cancers and solid...

This review summarizes the...

01/04/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

A Tumor Lysis Syndrome Risk Assessment and Its Impact on Patients

08/09/2022

In an interview with Journal of Clinical Pathways, Nicholas Short, MD, shares objectives on the design and benefits of MD Anderson’s Tumor Lysis Syndrome clinical assessment for patient risk and impact on patient care.

In an interview with Journal of...

08/09/2022

Journal of Clinical Pathways

Updated NCCN Guidelines on B-Cell Lymphomas

Sponsored

JCP Special Report

Overview of the Updated NCCN Guidelines on B-Cell Lymphomas

06/15/2022

Robert Fee ;

Updated multiple times in 2022, the National Comprehensive Cancer Network (NCCN) Guidelines for B-Cell Lymphomas provide recommendations for the prevention, diagnosis, and management of malignancies.

Updated multiple times in 2022,...

06/15/2022

Journal of Clinical Pathways

Sponsored

Special Report

Expanded Indication for Zanubrutinib: Marginal Zone Lymphoma and Waldenström’s Macroglobulinemia

06/10/2022

In an interview with Journal of Clinical Pathways, Mitul Gandhi, MD, reviews the clinical impact and treatment approaches and challenges for patients with marginal zone lymphoma and Waldenström’s macroglobulinemia.

In an interview with Journal of...

06/10/2022

Journal of Clinical Pathways

JCP Special Report

Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group

05/20/2022

Robin T. Zon , MD, FACP, FASCO;

Gordon Kuntz ;

Winston Wong , PharmD;

The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...

The Journal of Clinical Pathways...

05/20/2022

Journal of Clinical Pathways

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

Sponsored

Special Report

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

12/15/2021

Deborah Abrams Kaplan ;

NCCN released updates to its practice guidelines on treating triple-negative breast cancer, featuring updates on sacituzumab govitecan recommendations and more.

NCCN released updates to its...

12/15/2021

Journal of Clinical Pathways

Sponsored

Special Report

Navigating the Patient Journey for Unresectable Stage III Non-Small Cell Lung Cancer

09/16/2021

.ryan-test { display: none; } .body-content h3 { font-size: 18px; line-height: 18px; color: #000000; font-weight: 600px; } .related-content { display: none; } .body-content div > div:nth-of-type(3) .paragraph > h3 >...

.ryan-test { display:...

09/16/2021

Journal of Clinical Pathways

Journal of Clinical Pathways Newsletter

Feature

Current Issue

Special Reports

Subscribe

Specialties

Events

Year Round Education

HMP Global Products